OOIR: Observatory of International Research

Papers

(The H4-Index of Journal of Addiction Medicine is 24. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)

Article	Citations
Alcohol Consumption in Response to the COVID-19 Pandemic in the United States	184
Opioid Use Disorder and COVID-19: Crashing of the Crises	141
Innovation During COVID-19: Improving Addiction Treatment Access	121
Gambling During the COVID-19 Crisis – A Cause for Concern	89
Low Barrier Tele-Buprenorphine in the Time of COVID-19: A Case Report	64
Opioid Policy Changes During the COVID-19 Pandemic - and Beyond	63
The Relationship Between Children's Problematic Internet-related Behaviors and Psychological Distress During the Onset of the COVID-19 Pandemic: A Longitudinal Study	54
Evidence of Buprenorphine-precipitated Withdrawal in Persons Who Use Fentanyl	50
Recommended Use of Terminology in Addiction Medicine	43
The ASAM Clinical Practice Guideline on Alcohol Withdrawal Management	39
Optimizing Medication Treatment of Opioid Use Disorder During COVID-19 (SARS-CoV-2)	38
Cannabis Use During the COVID-19 Pandemic in Canada: A Repeated Cross-sectional Study	37
A Telemedicine Buprenorphine Clinic to Serve New York City: Initial Evaluation of the NYC Public Hospital System's Initiative to Expand Treatment Access During the COVID-19 Pandemic	35
“Like Yin and Yang”: Perceptions of Methamphetamine Benefits and Consequences Among People Who Use Opioids in Rural Communities	34
Rejection of Patients With Opioid Use Disorder Referred for Post-acute Medical Care Before and After an Anti-discrimination Settlement in Massachusetts	34
Impacts of the COVID-19 Shutdown on Gambling Patterns in Australia: Consideration of Problem Gambling and Psychological Distress	33
The Impacts of COVID-19 on Mental Health, Substance Use, and Overdose Concerns of People Who Use Drugs in Rural Communities	32
Disparities in Access to Medications for Opioid Use Disorder in the Veterans Health Administration	32
Low-dose Buprenorphine Initiation in Hospitalized Adults With Opioid Use Disorder: A Retrospective Cohort Analysis	31
Management of Xylazine Withdrawal in a Hospitalized Patient: A Case Report	30
Adapting a Low-threshold Buprenorphine Program for Vulnerable Populations During the COVID-19 Pandemic	29
Treatment of Kratom Withdrawal and Dependence With Buprenorphine/Naloxone: A Case Series and Systematic Literature Review	28
Retention Strategies for Medications for Opioid Use Disorder in Adults: A Rapid Evidence Review	27
Early Effects of COVID-19 on Programs Providing Medications for Opioid Use Disorder in Jails and Prisons	25
Policies to Improve Substance Use Disorder Treatment With Telehealth During the COVID-19 Pandemic and Beyond	24

Hospital-based Buprenorphine Micro-dose Initiation	24
Access to Healthcare and Harm Reduction Services During the COVID-19 Pandemic for People Who Use Drugs	24
Low Dose Initiation of Buprenorphine: A Narrative Review and Practical Approach	24